What development phase is Dibromoxin in?

Dibromoxin is FDA-approved (marketed).

What is the generic name of Dibromoxin?

BROXYQUINOLINE is the generic (nonproprietary) name of Dibromoxin.

Last reviewed 2026-04-20 · How we verify

Dibromoxin (BROXYQUINOLINE)

FDA-approved withdrawn Small molecule Quality 15/100

At a glance

Generic name	BROXYQUINOLINE
Drug class	broxyquinoline
Target	Catechol O-methyltransferase
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Dibromoxin CI brief — competitive landscape report
Dibromoxin updates RSS · CI watch RSS